Solventum Corp(SOLV)Stock Analysis

SOLV Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Solventum Corp (SOLV), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SOLV at 55.7/100 on a 32-signal composite quality model, placing it at rank #1,148 of 2,879 stocks — the top half of the AI-ranked universe. SOLV scores in the top quartile across balance sheet strength (87.7), revenue scale (84.6), profitability (81.1). Areas of concern include earnings quality (4.6) and revenue growth (21.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 41.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Solventum Corp reports quarterly revenue of $2.0B, net income of $13.0M, free cash flow of $-273.0M. Top institutional holders of SOLV by reported 13-F value include Independent Franchise Partners LLP, BlackRock,, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. SOLV trades on the NYSE exchange and files with the SEC under CIK 1964738. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SOLV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Solventum Corp directly from SEC EDGAR. Solventum Corp's 13F Pro composite quality score has ranged between 8 and 67 since 2025, currently 55.7 — a declining long-term trajectory across 40 quarterly and live scoring snapshots.